
In the lawsuit, the EU accuses Astrazeneca of failing to live up to their agreements concerning the supply of Covid-19 vaccine doses. The firm also stands accused of having no credible plan for delivering the doses within an acceptable time frame.
The contract stated that the pharmaceutical company was obligated to provide 180 million vaccine doses to the EU in the second quarter this year for EUR 300m (USD 362.4m).
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app